Motoneuron diseases (MNDs) are neurodegenerative conditions associated with death of upper and/or lower motoneurons (MNs). Proteostasis alteration is a pathogenic mechanism involved in many MNDs and is due to the excessive presence of misfolded and aggregated proteins. Protein misfolding may be the product of gene mutations, or due to defects in the translation process, or to stress agents; all these conditions may alter the native conformation of proteins making them prone to aggregate. Alternatively, mutations in members of the protein quality control (PQC) sys-tem may determine a loss of function of the proteostasis network. This causes an impairment in the capability to handle and remove aberrant or damaged proteins. The PQC system consists of the degradative pathways, which are the autophagy and the proteasome, and a network of chap-erones and co-chaperones. Among these components, Heat Shock Protein 70 represents the main factor in substrate triage to folding, refolding, or degradation, and it is assisted in this task by a subclass of the chaperone network, the small heat shock protein (sHSPs/HSPBs) family. HSPBs take part in proteostasis by bridging misfolded and aggregated proteins to the HSP70 machinery and to the degradative pathways, facilitating refolding or clearance of the potentially toxic pro-teins. Because of its activity against proteostasis alteration, the chaperone system plays a relevant role in the protection against proteotoxicity in MNDs. Here, we discuss the role of HSPBs in MNDs and which HSPBs may represent a valid target for therapeutic purposes.

The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases / B. Tedesco, V. Ferrari, M. Cozzi, M. Chierichetti, E. Casarotto, P. Pramaggiore, F. Mina, M. Galbiati, P. Rusmini, V. Crippa, R. Cristofani, A. Poletti. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 23:19(2022), pp. 11759.1-11759.24. [10.3390/ijms231911759]

The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases

B. Tedesco
Primo
;
V. Ferrari
Secondo
;
M. Cozzi;M. Chierichetti;E. Casarotto;P. Pramaggiore;F. Mina;M. Galbiati;P. Rusmini;V. Crippa;R. Cristofani
Penultimo
;
A. Poletti
Ultimo
2022

Abstract

Motoneuron diseases (MNDs) are neurodegenerative conditions associated with death of upper and/or lower motoneurons (MNs). Proteostasis alteration is a pathogenic mechanism involved in many MNDs and is due to the excessive presence of misfolded and aggregated proteins. Protein misfolding may be the product of gene mutations, or due to defects in the translation process, or to stress agents; all these conditions may alter the native conformation of proteins making them prone to aggregate. Alternatively, mutations in members of the protein quality control (PQC) sys-tem may determine a loss of function of the proteostasis network. This causes an impairment in the capability to handle and remove aberrant or damaged proteins. The PQC system consists of the degradative pathways, which are the autophagy and the proteasome, and a network of chap-erones and co-chaperones. Among these components, Heat Shock Protein 70 represents the main factor in substrate triage to folding, refolding, or degradation, and it is assisted in this task by a subclass of the chaperone network, the small heat shock protein (sHSPs/HSPBs) family. HSPBs take part in proteostasis by bridging misfolded and aggregated proteins to the HSP70 machinery and to the degradative pathways, facilitating refolding or clearance of the potentially toxic pro-teins. Because of its activity against proteostasis alteration, the chaperone system plays a relevant role in the protection against proteotoxicity in MNDs. Here, we discuss the role of HSPBs in MNDs and which HSPBs may represent a valid target for therapeutic purposes.
Motor Neuron Diseases; HSPBs; HSPB8; BAG3; autophagy; proteasome; protein misfiling; protein aggregation; proteostasis; protein quality control; chaperones amyotrophic lateral sclerosis; kennedy's disease; SBMA, ALS; polyglutamine; CAG repeat
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
   Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease
   EX_ALS
   KENNEDY'S DISEASE ASSOCIATION

   Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA
   GENDER-ALS
   FONDAZIONE TELETHON ETS
   GGP19128

   The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS)
   Target-RAN
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017F2A2C5_001

   Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
   MLOMALS
   AGENZIA ITALIANA DEL FARMACO - AIFA
   AIFA-2016-02364678

   The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis
   TRANS-ALS
   AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES

   Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
   TEAM
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2020PBS5MJ_005

   Translating molecular mechanisms into ALS risk and patient's well-being
   Co-ALS
   FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA
   2015-0023

   Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS)
   MLOMALS
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
   FONDAZIONE CARIPLO
   2021-1544

   Targeting RAN translation in ALS (Target-RAN)
   Target-RAN
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   Piano Sviluppo Unimi - Linea 3 - Bando SOE 2020 - Progetto GENDER-ALS
   GENDER-ALS
   UNIVERSITA' DEGLI STUDI DI MILANO
2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
ijms-23-11759.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 757.01 kB
Formato Adobe PDF
757.01 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/940182
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact